paid access
Scabies — review of the current diagnostic criteria and treatment recommendations
Affiliations- Zakład i Klinika Dermatologii, Instytut Nauk Medycznych, Kolegium Nauk Medycznych, Uniwersytet Rzeszowski
paid access
Abstract
Scabies is an ectoparasite skin disease caused by the mite Sarcoptes scabiei var. hominis. In 2020, the International Alliance for the Control of Scabies (IACS) developed the specific diagnostic criteria. Diagnosis is suspected on the basis of a suggestive history, an itch and clinical findings. However, an imaging examination (microscopic or dermoscopic) is required to make a definitive diagnosis. According to a guideline of European Academy of Dermatology and Venereology (EADV) recommended treatment includes a topical permethrin 5%, an oral ivermectin and a topical benzyl benzoate.
Abstract
Scabies is an ectoparasite skin disease caused by the mite Sarcoptes scabiei var. hominis. In 2020, the International Alliance for the Control of Scabies (IACS) developed the specific diagnostic criteria. Diagnosis is suspected on the basis of a suggestive history, an itch and clinical findings. However, an imaging examination (microscopic or dermoscopic) is required to make a definitive diagnosis. According to a guideline of European Academy of Dermatology and Venereology (EADV) recommended treatment includes a topical permethrin 5%, an oral ivermectin and a topical benzyl benzoate.
Full Text:
Add to basket: 49.00 PLN
Keywords
scabies, ivermectin, permetrin
About this articleTitle
Scabies — review of the current diagnostic criteria and treatment recommendations
Journal
Issue
Article type
Review paper
Pages
89-92
Published online
2022-06-30
Page views
1328
Article views/downloads
29
DOI
Bibliographic record
Forum Dermatologicum 2022;8(2):89-92.
Keywords
scabies
ivermectin
permetrin
Authors
Karolina Krawczyk
Adam Reich
References (26)- Engelman D, Yoshizumi J, Hay RJ, et al. The 2020 International Alliance for the Control of Scabies Consensus Criteria for the Diagnosis of Scabies. Br J Dermatol. 2020; 183(5): 808–820.
- GBD 2015 Disease and Injury Incidence and Prevalence Collaborators . Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016; 388(10053): 1545–1602.
- Leung V, Miller M. Detection of scabies: A systematic review of diagnostic methods . Can J Infect Dis Med Microbiol . 2011; 22(4): 143–146.
- Anderson KL, Strowd LC. Epidemiology, Diagnosis, and Treatment of Scabies in a Dermatology Office. J Am Board Fam Med. 2017; 30(1): 78–84.
- Chandler DJ, Fuller LC. A Review of Scabies: An Infestation More than Skin Deep. Dermatology. 2019; 235(2): 79–90.
- Hicks MI, Elston DM. Scabies. Dermatol Ther. 2009; 22(4): 279–292.
- Suh KS, Han SH, Lee KH, et al. Mites and burrows are frequently found in nodular scabies by dermoscopy and histopathology. J Am Acad Dermatol. 2014; 71(5): 1022–1023.
- Orkin M. Special forms of scabies. In: Orkin M. ed. Scabies and pediculosis. Lippincott, Philadelphia 1977.
- Salavastru CM, Chosidow O, Boffa MJ, et al. European guideline for the management of scabies. J Eur Acad Dermatol Venereol. 2017; 31(8): 1248–1253.
- Sunderkötter C, Wohlrab J, Hamm H. Scabies: Epidemiology, Diagnosis, and Treatment. Dtsch Arztebl Int. 2021; 118(41): 695–704.
- Hill TA, Cohen B. Scabies in babies. Pediatr Dermatol. 2017; 34(6): 690–694.
- Levy M, Martin L, Bursztejn A, et al. Ivermectin safety in infants and children under 15 kg treated for scabies: a multicentric observational study. Br J Dermatol. 2019; 182(4): 1003–1006.
- Kosmala A, Szymoniak-Lipska M, Jałowska M, et al. Crusted scabies in a patient with systemic disorders – evaluation of ivermectin treatment results. Dermatol Rev. 2019; 106(6): 671–679.
- Hu S, Bigby M. Treating scabies: results from an updated Cochrane review. Arch Dermatol. 2008; 144(12): 1638–1640.
- Rosumeck S, Nast A, Dressler C. Evaluation of Ivermectin vs Permethrin for Treating Scabies-Summary of a Cochrane Review. JAMA Dermatol. 2019; 155(6): 730–732.
- Dhana A, Yen H, Okhovat JP, et al. Ivermectin versus permethrin in the treatment of scabies: A systematic review and meta-analysis of randomized controlled trials. J Am Acad Dermatol. 2018; 78(1): 194–198.
- Sunderkötter C, Feldmeier H, Fölster-Holst R, et al. S1 guidelines on the diagnosis and treatment of scabies - short version. J Dtsch Dermatol Ges. 2016; 14(11): 1155–1167.
- Hamm H, Beiteke U, Höger PH, et al. Treatment of scabies with 5% permethrin cream: results of a German multicenter study. J Dtsch Dermatol Ges. 2006; 4(5): 407–413.
- Hicks MI, Elston DM. Scabies. Dermatol Ther. 2009; 22(4): 279–292.
- Goldust M, Rezaee E, Raghifar R, et al. Treatment of scabies: the topical ivermectin vs. permethrin 2.5% cream. Ann Parasitol. 2013; 59(2): 79–84.
- Romani L, Whitfeld MJ, Koroivueta J, et al. Mass Drug Administration for Scabies Control in a Population with Endemic Disease. N Engl J Med. 2015; 373(24): 2305–2313.
- Subramaniam S, Rutman MS, Wenger JK. A papulopustular, vesicular, crusted rash in a 4-week-old neonate. Pediatr Emerg Care. 2013; 29(11): 1210–1212.
- Cestari TF, Martignago BF. Scabies, pediculosis, bedbugs, and stinkbugs: uncommon presentations. Clin Dermatol. 2005; 23(6): 545–554.
- Currie BJ, McCarthy JS. Permethrin and ivermectin for scabies. N Engl J Med. 2010; 362(8): 717–725.
- Goldust M, Rezaee E, Hemayat S. Treatment of scabies: Comparison of permethrin 5% versus ivermectin. J Dermatol. 2012; 39(6): 545–547.
- Usha V, Gopalakrishnan Nair TV. A comparative study of oral ivermectin and topical permethrin cream in the treatment of scabies. J Am Acad Dermatol. 2000; 42(2 Pt 1): 236–240.
